Work

Abstract CT083: Ph1b evaluation of ADG126 (muzastotug, an anti-CTLA-4 masking antibody) pembrolizumab (Pembro) IO doublet in combination with fruquintinib (Fruq) in advanced and metastatic microsatellite stable colorectal cancer

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct083

Authors: Marwan Fakih, Sunil Sharma, Manish R. Patel, Daneng Li, Yan Li, Luke Chung, Songmao Zheng, Xiaohong She, Stanley Frankel, Michael J. Chisamore, Peter Luo, Jiping Zha

Institutions: City of Hope, HonorHealth, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154712059

Cites:

Cited by:

Related to: